The global vitamin supplements market size accounted for USD 51.68 billion in 2024, grew to USD 55.19 billion in 2025 and is predicted to surpass around USD 99.78 billion by 2034, representing a healthy CAGR of 6.80% between 2024 and 2034. The North America vitamin supplements market size is calculated at USD 20.16 billion in 2024 and is expected to grow at a fastest CAGR of 6.92% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Vitamin Supplements Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Vitamin Supplements Market, by Type, 2024-2034
8.1.1. Vitamin A
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Vitamin B
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Vitamin C
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Vitamin D
8.1.4.1. Market Revenue and Forecast (2021-2034)
8.1.5. Vitamin E
8.1.5.1. Market Revenue and Forecast (2021-2034)
8.1.6. Vitamin K
8.1.6.1. Market Revenue and Forecast (2021-2034)
8.1.7. Multivitamin
8.1.7.1. Market Revenue and Forecast (2021-2034)
9.1. Vitamin Supplements Market, by Form, 2024-2034
9.1.1. Tablets
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Powder
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Capsule
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Gummies
9.1.4.1. Market Revenue and Forecast (2021-2034)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2021-2034)
10.1. Vitamin Supplements Market, by Distribution Channel, 2024-2034
10.1.1. Supermarkets and hypermarkets
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Retail Pharmacy
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Online sales
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2021-2034)
11.1. Vitamin Supplements Market, by End User, 2024-2034
11.1.1. Adult
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Geriatric
11.1.2.1. Market Revenue and Forecast (2021-2034)
12.1. North America
12.1.1. Market Revenue and Forecast, by Type (2021-2034)
12.1.2. Market Revenue and Forecast, by Form (2021-2034)
12.1.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.1.4. Market Revenue and Forecast, by End User (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Type (2021-2034)
12.1.5.2. Market Revenue and Forecast, by Form (2021-2034)
12.1.5.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.1.5.4. Market Revenue and Forecast, by End User (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Type (2021-2034)
12.1.6.2. Market Revenue and Forecast, by Form (2021-2034)
12.1.6.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.1.6.4. Market Revenue and Forecast, by End User (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Type (2021-2034)
12.2.2. Market Revenue and Forecast, by Form (2021-2034)
12.2.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.2.4. Market Revenue and Forecast, by End User (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Type (2021-2034)
12.2.5.2. Market Revenue and Forecast, by Form (2021-2034)
12.2.5.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.2.5.4. Market Revenue and Forecast, by End User (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Type (2021-2034)
12.2.6.2. Market Revenue and Forecast, by Form (2021-2034)
12.2.6.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.2.6.4. Market Revenue and Forecast, by End User (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Type (2021-2034)
12.2.7.2. Market Revenue and Forecast, by Form (2021-2034)
12.2.7.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.2.7.4. Market Revenue and Forecast, by End User (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Type (2021-2034)
12.2.8.2. Market Revenue and Forecast, by Form (2021-2034)
12.2.8.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.2.8.4. Market Revenue and Forecast, by End User (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Type (2021-2034)
12.3.2. Market Revenue and Forecast, by Form (2021-2034)
12.3.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.3.4. Market Revenue and Forecast, by End User (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Type (2021-2034)
12.3.5.2. Market Revenue and Forecast, by Form (2021-2034)
12.3.5.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.3.5.4. Market Revenue and Forecast, by End User (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Type (2021-2034)
12.3.6.2. Market Revenue and Forecast, by Form (2021-2034)
12.3.6.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.3.6.4. Market Revenue and Forecast, by End User (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Type (2021-2034)
12.3.7.2. Market Revenue and Forecast, by Form (2021-2034)
12.3.7.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.3.7.4. Market Revenue and Forecast, by End User (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Type (2021-2034)
12.3.8.2. Market Revenue and Forecast, by Form (2021-2034)
12.3.8.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.3.8.4. Market Revenue and Forecast, by End User (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Type (2021-2034)
12.4.2. Market Revenue and Forecast, by Form (2021-2034)
12.4.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.4.4. Market Revenue and Forecast, by End User (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Type (2021-2034)
12.4.5.2. Market Revenue and Forecast, by Form (2021-2034)
12.4.5.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.4.5.4. Market Revenue and Forecast, by End User (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Type (2021-2034)
12.4.6.2. Market Revenue and Forecast, by Form (2021-2034)
12.4.6.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.4.6.4. Market Revenue and Forecast, by End User (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Type (2021-2034)
12.4.7.2. Market Revenue and Forecast, by Form (2021-2034)
12.4.7.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.4.7.4. Market Revenue and Forecast, by End User (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Type (2021-2034)
12.4.8.2. Market Revenue and Forecast, by Form (2021-2034)
12.4.8.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.4.8.4. Market Revenue and Forecast, by End User (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Type (2021-2034)
12.5.2. Market Revenue and Forecast, by Form (2021-2034)
12.5.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.5.4. Market Revenue and Forecast, by End User (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Type (2021-2034)
12.5.5.2. Market Revenue and Forecast, by Form (2021-2034)
12.5.5.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.5.5.4. Market Revenue and Forecast, by End User (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Type (2021-2034)
12.5.6.2. Market Revenue and Forecast, by Form (2021-2034)
12.5.6.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.5.6.4. Market Revenue and Forecast, by End User (2021-2034)
13.1. Amway Corp.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. American Health Formulations (AHF)
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. American Health Formulations (AHF)
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Garden of Life, LLC.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Good Health New Zealand
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Healthy Life Pharma (P) Limited
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Klean Athlete
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Llama Naturals
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. NOW Foods
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Nordic Naturals
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample